1. Home
  2. SSTK vs IAM Comparison

SSTK vs IAM Comparison

Compare SSTK & IAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shutterstock Inc.

SSTK

Shutterstock Inc.

N/A

Current Price

$2.20

Market Cap

570.9M

Sector

Technology

ML Signal

N/A

IAM

Iambic Therapeutics Inc. Common Stock

N/A

Current Price

$13.09

Market Cap

683.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SSTK
IAM
Founded
2003
2019
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
570.9M
683.0M
IPO Year
2012
2026

Fundamental Metrics

Financial Performance
Metric
SSTK
IAM
Price
$2.20
$13.09
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $27.25
AVG Volume (30 Days)
★ 901.5K
456.0K
Earning Date
11-05-2026
11-16-2026
Dividend Yield
★ 44.49%
N/A
EPS Growth
★ 23.76
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$704.85
Revenue Next Year
N/A
$17.37
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.20
$9.60
52 Week High
$21.68
$24.49

Technical Indicators

Market Signals
Indicator
SSTK
IAM
Relative Strength Index (RSI) 24.82 35.29
Support Level N/A $10.99
Resistance Level $4.67 $15.44
Average True Range (ATR) 0.33 1.98
MACD -0.08 0.40
Stochastic Oscillator 1.24 54.40

Price Performance

Historical Comparison
SSTK
IAM

About SSTK Shutterstock Inc.

Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.

About IAM Iambic Therapeutics Inc. Common Stock

Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.

Share on Social Networks: